NCT05821660

Brief Summary

The aim of this study is to assess changes in body and metabolism caused by this new five-day hypocaloric and ketogenic programme

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 20, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 17, 2023

Completed
Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

5 months

First QC Date

March 22, 2023

Last Update Submit

September 26, 2025

Conditions

Keywords

hypocaloric and ketogenic dietintestinal microbiotainflammatory status

Outcome Measures

Primary Outcomes (3)

  • Changes in body weight

    in kg

    through study completion (11 subsequent days as well as one month afterwards)

  • Changes in systolic blood pressure

    in mmHg

    through study completion (11 subsequent days as well as one month afterwards)

  • Changes in diastolic blood pressure

    in mmHg

    through study completion (11 subsequent days as well as one month afterwards)

Secondary Outcomes (17)

  • Changes in acetoacetic acid

    through study completion (11 subsequent days as well as one month afterwards)

  • Changes in total cholesterol

    At baseline, after 5 and 9 days as well as 1 month afterwards

  • Changes in HDL-C

    At baseline, after 5 and 9 days as well as 1 month afterwards

  • Changes in LDL-C

    At baseline, after 5 and 9 days as well as 1 month afterwards

  • Changes in triglycerides

    At baseline, after 5 and 9 days as well as 1 month afterwards

  • +12 more secondary outcomes

Other Outcomes (54)

  • Changes in body mass index

    through study completion (11 subsequent days as well as one month afterwards)

  • Changes in abdominal circumference

    through study completion (11 subsequent days as well as one month afterwards)

  • Changes in resting heart frequency

    through study completion (11 subsequent days as well as one month afterwards)

  • +51 more other outcomes

Study Arms (2)

Five-day hypocaloric and ketogenic programme

EXPERIMENTAL

The group will receive a five-day remotely delivered hypocaloric and ketogenic programme followed by a four-day food reintroduction period

Other: Five-day hypocaloric and ketogenic programme

Control

NO INTERVENTION

The group will maintain their habitual diet

Interventions

Dietary intervention

Also known as: Buchinger Wilhelmi Fastingbox
Five-day hypocaloric and ketogenic programme

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Not able to sign the informed consent
  • diagnosticated with cachexia, anorexia, nervosa, advanced kidney, liver or cerebrovascular insufficiency.
  • Intake of antibiotics up to 2 months prior the study
  • Medicated high blood pressure
  • Diagnosed hyperuricemia
  • Diagnosed diabetes mellitus type I and II
  • Diagnosed kidney stone
  • Active malignant diseases
  • Known substance addiction
  • Pregnancy or breastfeeding
  • Participation in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Buchinger Wilhelmi Clinic

Überlingen, Baden-Wurttemberg, 88662, Germany

Location

Study Officials

  • Françoise Wilhelmi de Toledo, Dr.

    Buchinger Wilhelmi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Prospective, two-arm interventional study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2023

First Posted

April 20, 2023

Study Start

April 1, 2023

Primary Completion

August 17, 2023

Study Completion

August 17, 2023

Last Updated

October 1, 2025

Record last verified: 2025-09

Locations